K-numberK242385
Device nameLED Therapy Mask (MN1, M226)
ApplicantShenzhen Borria Technology Co., Ltd.
Product codeOHS
Device classClass II
Decision dateApr 7, 2025
DecisionSubstantially Equivalent
Regulation878.4810
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The LED Therapy Mask (models MN1, M226) is a wearable, home-use phototherapy device that emits narrow-band LED light at multiple wavelengths to treat facial wrinkles, mild-to-moderate inflammatory acne, and provide topical heating for arthritis and muscle conditions. It consists of a mask unit containing LEDs, a controller with rechargeable lithium battery, straps, and a charging cable. The device produces red (630nm), blue (460nm), infrared (850nm), and mixed light wavelengths depending on the selected mode.

Technological characteristics

The subject device uses LEDs generating four wavelengths (red 630nm, blue 470nm, infrared 850nm, mixed 630nm+850nm) with intensity ranges of 0.89–4.09 mW/cm², powered by a built-in 3.7V 2500mAh lithium battery. Key differences from the predicate include slightly different blue wavelength (470nm vs 460nm), lower mixed-light intensity (0.95–2.64 mW/cm² vs 9.0–12.0 mW/cm²), different dimensions, and 10-minute treatment time versus the predicate's 10–15 minutes.

Test standards cited

Biocompatibility testing per ISO 10993-5, 10993-10, and 10993-23; electrical safety and EMC per IEC 60601-1, 60601-1-2, 60601-1-11, 60601-2-83, and IEC 62133-2; eye safety per IEC 62471; and software validation per FDA's Human Factors guidance (February 2016).

Substantial equivalence argument

The device is substantially equivalent because it uses the same fundamental technology (LED phototherapy), targets identical indications (wrinkles, acne, heating), is classified identically (Class II), and meets the same regulatory standards as the predicate device. Although there are minor differences in wavelength precision, intensity levels, and treatment duration, these variations fall within acceptable ranges observed across reference devices and do not raise new safety or effectiveness concerns. The device passed all biocompatibility, electrical safety, and software validation testing, demonstrating it performs comparably to the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →